Astellas, University of Tokyo extend partnershi...
Home | Astellas Pharma Canada, Inc.
Astellas' Prostate Cancer Drug Available In Jap...
FDA blocks Astellas’ Claudin cancer drug over m...
Astellas Pharma Joins Record Bond Sales by Japa...
Asia Business Daily on Twitter: "Astellas Pharm...
Astellas Pharma on LinkedIn: 医薬品の枠を超えた...
Атлас лекарственных растений - YouTube
Astellas gets FDA priority review for gastric c...
Главная | Astellas Pharma Russia
Pharmaceutical Technology
Astellas introduces sustainable community initi...
Astellas Pharma to acquire Propella Therapeutic...
Astellas licenses 4DMT’s AAV vector for ophthal...
China Formally Arrests Japanese Employee of Dru...
Astellas Pharma: A Contrarian Investment (OTCMK...
Astellas Pharma
FDA Grants Full Approval for Astellas Pharma's ...
Astellas Pharma EMEA celebrates its 10th annive...
Astellas Home page | Astellas Pharma Inc.
Astellas Pharma US on LinkedIn: FDA Grants Prio...
Astellas Pharma - Global Web Site on Behance
Astellas Sues Over New Myrbetriq Patent to Reca...
Astellas Pharma Inc. (4503N.MX) stock price, ne...
Japan's Astellas sees cancer drug fueling 29% p...
Astellas Trains Sights On Iveric Bio In $5.9 Bi...
Astellas
FDA Approves Astellas’ Non-hormonal Menopause T...
Astellas Pharmaceuticals Establishes Open Innov...
About | Astellas Pharma Ltd
Astellas Offloads 5 Legacy Products to Germany’...
Astellas Pharma Projects :: Photos, videos, log...
US FDA approves Astellas Pharma pill for menopa...